• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prediction models in urology: are they any good, and how would we know anyway?

作者信息

Vickers Andrew

出版信息

Eur Urol. 2010 Apr;57(4):571-3; discussion 574. doi: 10.1016/j.eururo.2009.12.026. Epub 2009 Dec 29.

DOI:10.1016/j.eururo.2009.12.026
PMID:20071072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2891896/
Abstract
摘要

相似文献

1
Prediction models in urology: are they any good, and how would we know anyway?泌尿外科中的预测模型：它们有用吗？无论如何我们又该如何知晓？
Eur Urol. 2010 Apr;57(4):571-3; discussion 574. doi: 10.1016/j.eururo.2009.12.026. Epub 2009 Dec 29.
2
Comparing prediction tools.比较预测工具。
Eur Urol. 2010 Apr;57(4):569-70; discussion 574. doi: 10.1016/j.eururo.2010.01.006. Epub 2010 Jan 14.
3
Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy.三种最常用的术前模型预测前列腺癌根治术后生化复发的头对头比较。
Eur Urol. 2010 Apr;57(4):562-8. doi: 10.1016/j.eururo.2009.12.003. Epub 2009 Dec 10.
4
Editorial comment on: prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy.关于“根治性前列腺切除术后超敏前列腺特异性抗原水平检测不到的预后意义”的编辑评论
Eur Urol. 2010 Apr;57(4):629-30. doi: 10.1016/j.eururo.2009.03.078. Epub 2009 Apr 3.
5
Editorial comment on: prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy.关于“根治性前列腺切除术后超敏前列腺特异性抗原水平检测不到的预后意义”的社论评论
Eur Urol. 2010 Apr;57(4):630. doi: 10.1016/j.eururo.2009.03.079. Epub 2009 Apr 3.
6
Natural history of patients presenting biochemical recurrence after radical prostatectomy: some good news?前列腺癌根治术后出现生化复发患者的自然病程：有好消息吗？
Eur Urol. 2011 Jun;59(6):900-1. doi: 10.1016/j.eururo.2011.02.043. Epub 2011 Mar 17.
7
Pretreatment prostate-specific antigen velocity and the risk of death from prostate cancer in the individual with low-risk prostate cancer.低风险前列腺癌患者的治疗前前列腺特异性抗原变化率与前列腺癌死亡风险
J Clin Oncol. 2009 Aug 1;27(22):3575-6. doi: 10.1200/JCO.2009.22.6068. Epub 2009 Jun 8.
8
Prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy.根治性前列腺切除术后超敏前列腺特异性抗原水平无法检测的预后意义。
Eur Urol. 2010 Apr;57(4):622-9. doi: 10.1016/j.eururo.2009.03.077. Epub 2009 Apr 3.
9
Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomy.在接受根治性前列腺切除术的患者中，治疗前前列腺特异性抗原（PSA）速率和倍增时间与预后相关，但二者均不能单独改善仅依据治疗前PSA对预后的预测。
J Clin Oncol. 2009 Aug 1;27(22):3591-7. doi: 10.1200/JCO.2008.19.9794. Epub 2009 Jun 8.
10
Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.辅助治疗初治患者根治性前列腺切除术后切缘阳性对前列腺特异抗原失败的影响。
BJU Int. 2011 Jun;107(11):1748-54. doi: 10.1111/j.1464-410X.2010.09728.x. Epub 2010 Sep 30.

引用本文的文献

1
Positive STAT5 Protein and Locus Amplification Status Predicts Recurrence after Radical Prostatectomy to Assist Clinical Precision Management of Prostate Cancer.STAT5 蛋白阳性和基因扩增状态可预测前列腺癌根治术后复发，有助于前列腺癌的临床精准管理。
Cancer Epidemiol Biomarkers Prev. 2019 Oct;28(10):1642-1651. doi: 10.1158/1055-9965.EPI-18-1358. Epub 2019 Jul 10.
2
External Validation of the Cancer of the Prostate Risk Assessment Postsurgical Score for Prediction of Disease Recurrence after Radical Prostatectomy.前列腺癌术后风险评估评分对根治性前列腺切除术后疾病复发预测的外部验证
Adv Med. 2016;2016:8639041. doi: 10.1155/2016/8639041. Epub 2016 Oct 19.
3
A Nomogram for Predicting the Likelihood of Obstructive Sleep Apnea to Reduce the Unnecessary Polysomnography Examinations.一种用于预测阻塞性睡眠呼吸暂停可能性以减少不必要多导睡眠图检查的列线图。
Chin Med J (Engl). 2015 Aug 20;128(16):2134-40. doi: 10.4103/0366-6999.162514.
4
Cancer of the Prostate Risk Assessment (CAPRA) Preoperative Score Versus Postoperative Score (CAPRA-S): ability to predict cancer progression and decision-making regarding adjuvant therapy after radical prostatectomy.前列腺癌风险评估（CAPRA）术前评分与术后评分（CAPRA-S）：预测癌症进展的能力及根治性前列腺切除术后辅助治疗的决策制定。
J Korean Med Sci. 2014 Sep;29(9):1212-6. doi: 10.3346/jkms.2014.29.9.1212. Epub 2014 Sep 2.
5
Risk prediction scores for recurrence and progression of non-muscle invasive bladder cancer: an international validation in primary tumours.非肌肉浸润性膀胱癌复发和进展的风险预测评分：原发性肿瘤的国际验证
PLoS One. 2014 Jun 6;9(6):e96849. doi: 10.1371/journal.pone.0096849. eCollection 2014.
6
External validation of the cancer of the prostate risk assessment-s score in koreans undergoing radical prostatectomy.接受根治性前列腺切除术的韩国人中前列腺癌风险评估 - S评分的外部验证
Korean J Urol. 2013 Jul;54(7):433-6. doi: 10.4111/kju.2013.54.7.433. Epub 2013 Jul 15.
7
The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy.CAPRA-S 评分：一种用于改善根治性前列腺切除术预后预测的简单工具。
Cancer. 2011 Nov 15;117(22):5039-46. doi: 10.1002/cncr.26169. Epub 2011 Jun 3.

本文引用的文献

1
Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy.三种最常用的术前模型预测前列腺癌根治术后生化复发的头对头比较。
Eur Urol. 2010 Apr;57(4):562-8. doi: 10.1016/j.eururo.2009.12.003. Epub 2009 Dec 10.
2
Development of a prostate cancer metagram: a solution to the dilemma of which prediction tool to use in patient counseling.前列腺癌元图表的开发：解决患者咨询中使用何种预测工具这一困境的方案。
Cancer. 2009 Jul 1;115(13 Suppl):3039-45. doi: 10.1002/cncr.24355.
3
Preoperative and postoperative nomograms incorporating surgeon experience for clinically localized prostate cancer.纳入外科医生经验的临床局限性前列腺癌术前和术后列线图。
Cancer. 2009 Mar 1;115(5):1005-10. doi: 10.1002/cncr.24083.
4
Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer.预测前列腺癌根治性前列腺切除术后早期复发概率的列线图。
J Urol. 2009 Feb;181(2):601-7; discussion 607-8. doi: 10.1016/j.juro.2008.10.033. Epub 2008 Dec 13.
5
An updated catalog of prostate cancer predictive tools.前列腺癌预测工具的最新目录。
Cancer. 2008 Dec 1;113(11):3075-99. doi: 10.1002/cncr.23908.
6
Recent trends in Gleason grading of prostate cancer: I. Pattern interpretation.前列腺癌Gleason分级的近期趋势：I. 模式解读。
Anal Quant Cytol Histol. 2008 Aug;30(4):190-8.
7
The Prostate Cancer Prevention Trial and European Randomized Study of Screening for Prostate Cancer risk calculators indicating a positive prostate biopsy: a comparison.前列腺癌预防试验与欧洲前列腺癌筛查随机研究中前列腺活检呈阳性的风险计算器比较
BJU Int. 2008 Nov;102(9):1068-73. doi: 10.1111/j.1464-410X.2008.07940.x. Epub 2008 Aug 18.
8
Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers.通过一组术前血液生物标志物改善前列腺癌根治术后疾病复发的预测
Clin Cancer Res. 2008 Jun 15;14(12):3785-91. doi: 10.1158/1078-0432.CCR-07-4969.
9
Predicting an optimal outcome after radical prostatectomy: the trifecta nomogram.预测根治性前列腺切除术后的最佳结果：三联预后列线图
J Urol. 2008 Jun;179(6):2207-10; discussion 2210-1. doi: 10.1016/j.juro.2008.01.106. Epub 2008 Apr 18.
10
Predicting outcomes in prostate cancer: how many more nomograms do we need?预测前列腺癌的预后：我们还需要多少列线图？
J Clin Oncol. 2007 Aug 20;25(24):3563-4. doi: 10.1200/JCO.2007.12.2721.